2Tasaka y,Yanagisawa k,Iwamoto Y,et al.Human plasma leptin in obese subjects and diabetes〔J〕[].The Journal of Endocrinology.1997
3Mark AL,Shaffer RA,Correia MLG,et al.Contrasting blood pressure effects of obesity in leptin deficient ob/ob mice and agouti yellow obese mice[].Journal of Hypertension.1999
4Heymsfield IS.Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial[].The Journal of The American Medical Association.1999
5Ogawa Y,Masuzaki H,Hosoda K,et al.Increased glucose metabolism and insulin sensitivity in Transgenic Skinny Mice overexpressing leptin[].Diabetes.1999
6Passaro A,Calzoni F,Zamboni PF,et al.Role of diabetes in influencing leptin concrenatration in elderly overweight patients[].European Journal of Endocrinology.2001
7Assali AR,Ganor A,Beigel Y,et al.Insulin resistance inobesity: body-weight or energy balance? 〔J〕[].The Journal of Endocrinology.2001
8Bastard JP,Jardel C,Bruckert E,et al.Elevated levels of interleukin 6 reduced in serum and subcutaneous adipose tissue of obese women after weight loss〔J〕[].The Journal of Clinical Endocrinology.2000
9Makata M,Yada T,Soejima N,et al.Leptin promotes aggregation of human platelets via the long form of its receptor[].Diabetes.1999
10Laivuori H,Kaaja R,Koistinen H,et al.Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity〔J〕[].Metabolism.2000
2Stamberj. Vaccaro Oneaton. JD et al. Diabetes. Other nisk-factor and 12 - yr cardiovas culor mortality for men scnened with Multiple Risk Factor Intervertion Trid Diabetes Care 1993 ;16:434.
3Domingo TL. Gomei M. Liobet J M. et al, Oral vanadion adminis- tration to strertozotocin diabetic rats has marked regative sideeffects whiehare independent of the form of vandium used Toxicogu 1991;66:279.
4Vankatesan N. AvidineA and Davidson MB. Autidiabetic ation of Vanadyl in rats independent of in vivo insulinreceptor kinase activity Diabetes 1991;40:492.
5Verier R, Lombardi AM, Fabfis R, et al. Substmte competition and insulin action in animal models[ J]. Int J Obes Relat Metab Disord ,2000,24[Suppl 2] :s22-24.
6Assali AR, Ganor A, Beigel Y, et al. Insulin resistance in obesity:body-weight or energy balance? [J]. J Endocrinol, 2001, 171 (2):293.
7Tsuboyyama KN, Takahashi M, Tanemura K, et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice [J] .Diabetes,2000,49(9) : 1534.
8Kondo H, Shimomura I, Katsukawa Y, et al. Association of adiponectin mu-tation with type 2 diabetes:a candidate gene for the insulin resistance syndrome J[J]. Diabetes,2002,51 (7) : 23-25.
9Hotta K, Funabashi T, Bodkin NL, et al. Circulating concentrations of the adipocyte protein adiponeetin are decreased in parallel with reguced insulin sensitivity during the pmgrssion to type 2 diabetes in rhesus monkeys[J]. Diabetes, 2001,50(5) : 1126.
10Yamauchi T,Oike Y, Kamon J, ez al. Increased insulin sensitivity despite lipodystrophy in crebbp heternsygous mice [ J]. Net Genet, 2002,30(2) :211.
